Earlier quoted context omitted.
Are you sure the NIH is critical for the pharma industry? Pharma companies generally conclude that replication rates of academic grant funded medical research are so low as to not be worth bothering with. From Amgen: "Over the past decade, before pursuing a particular line of research, scientists (including C.G.B.) in the haematology and oncology department at the biotechnology firm Amgen in Thousand Oaks, California…
It’s rare to find someone argue that confirming only 25% of a massive amount of output enabled only because of the in place system is a good reason to eliminate the system. It’s kind of like saying “solar panels are only 20% efficient, so are you sure the sun is critical for the solar energy industry?”
25% is crazy low, but 11% is even lower. If someone told you things and 90% of the time they were wrong, you'd stop listening.
Solar panels having low effectiveness would actually be a good argument against them, because although the solar industry needs solar panels the correct comparison is with the energy industry overall, which doesn't.